Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.47% | $214.31M | €461.36B | 67.14% | 76 Outperform | |
| Roche Holding AG | 1.44% | $124.85M | CHF285.32B | 41.42% | 73 Outperform | |
| AstraZeneca | 1.39% | $120.46M | £229.75B | 23.85% | 80 Outperform | |
| HSBC Holdings | 1.36% | $117.68M | £224.21B | 49.04% | 80 Outperform | |
| Novartis AG | 1.35% | $116.79M | CHF234.28B | 25.89% | 80 Outperform | |
| Nestlé SA | 1.16% | $100.53M | CHF197.91B | 9.29% | 71 Outperform | |
| Siemens | 1.02% | $88.85M | €199.94B | 14.38% | 74 Outperform | |
| Toyota Motor | 1.02% | $88.33M | ¥48.41T | 32.64% | 80 Outperform | |
| Shell (UK) | 1.02% | $88.33M | £164.82B | 9.90% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 1.01% | $87.33M | ¥33.93T | 56.43% | 76 Outperform |